RCUS

SEC source: 0001209191-20-034984 · doc4.xml · derivative · entry 2

Jarrett Jennifer · CIK 0001671311 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Stock · 14,000 shares

Expires 2030-06-03

F3 · derivative.exercise_date: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.

SEC source: 0001209191-20-034984 · doc4.xml · nonDerivative · entry 1

Jarrett Jennifer · CIK 0001671311 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,634

F1 · shares: Represents the grant of restricted stock units that vest 100% on the earlier of June 4, 2021 or the next annual meeting of the stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control

F2 · balance_after: Includes 608 shares purchased on 11/30/2018 through the Company's Employee Stock Purchase Plan.

SEC source: 0001209191-20-034978 · doc4.xml · nonDerivative · entry 1

Grossman William · CIK 0001730229 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,400

F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments after June 4, 2020, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-20-034974 · doc4.xml · nonDerivative · entry 1

Barker Jason · CIK 0001426883 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments after June 4, 2020, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-20-034977 · doc4.xml · derivative · entry 3

FALBERG KATHRYN E · CIK 0001206977 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Stock · 14,000 shares

Expires 2030-06-03

F2 · derivative.exercise_date: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.

SEC source: 0001209191-20-034977 · doc4.xml · nonDerivative · entry 1

FALBERG KATHRYN E · CIK 0001206977 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,504

F1 · shares: Represents the grant of restricted stock units that vest 100% on the earlier of June 4, 2021 or the next annual meeting of the stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.

SEC source: 0001209191-20-032004 · doc4.xml · derivative · entry 1

Lacey David L. · CIK 0001734422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2030-05-20

F1 · derivative.exercise_date: The option is exercisable in 36 equal monthly installments after May 21, 2020, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-20-004398 · doc4.xml · derivative · entry 1

Grossman William · CIK 0001730229 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 140,000 shares

Expires 2029-12-31

F1 · derivative.exercise_date: The option is exercisable in 48 equal monthly installments after January 1, 2020, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-20-004405 · doc4.xml · derivative · entry 1

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2029-12-31

F1 · derivative.exercise_date: The option is exercisable in 48 equal monthly installments after January 1, 2020, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-20-004403 · doc4.xml · derivative · entry 1

Ribas Antoni · CIK 0001792164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2029-12-31

F1 · shares: Award made to members of Arcus's Scientific Advisory Board.

F2 · derivative.exercise_date: The option is exercisable in 24 equal monthly installments after January 1, 2020, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-20-004401 · doc4.xml · derivative · entry 1

Jaen Juan C. · CIK 0001422996 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2029-12-31

F1 · derivative.exercise_date: The option is exercisable in 48 equal monthly installments after January 1, 2020, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-20-004396 · doc4.xml · derivative · entry 1

Barker Jason · CIK 0001426883 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2029-12-31

F1 · derivative.exercise_date: The option is exercisable in 48 equal monthly installments after January 1, 2020, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-19-060168 · doc4.xml · derivative · entry 1

Machado Patrick · CIK 0001311210 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2029-12-09

F1 · derivative.exercise_date: The option is exercisable in 36 equal monthly installments after December 10, 2019, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-19-054500 · doc4.xml · derivative · entry 1

Ribas Antoni · CIK 0001792164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common stock · 50,000 shares

Expires 2029-10-27

F1 · derivative.exercise_date: The option is exercisable in 36 equal monthly installments after October 28, 2019, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-19-053207 · doc4.xml · nonDerivative · entry 2

Grossman William · CIK 0001730229 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

SEC source: 0001209191-19-053207 · doc4.xml · nonDerivative · entry 1

Grossman William · CIK 0001730229 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

SEC source: 0001209191-19-039547 · doc4.xml · nonDerivative · entry 2

Jaen Juan C. · CIK 0001422996 · Director · President

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 2,779,240

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.69 to $8.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-039547 · doc4.xml · nonDerivative · entry 1

Jaen Juan C. · CIK 0001422996 · Director · President

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 2,774,346

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.32 to $7.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-037024 · doc4.xml · nonDerivative · entry 1

FALBERG KATHRYN E · CIK 0001206977 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 82,106

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.45 to $8.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-036960 · doc4.xml · nonDerivative · entry 2

FALBERG KATHRYN E · CIK 0001206977 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 69,171

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.39 to $8.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-036960 · doc4.xml · nonDerivative · entry 1

FALBERG KATHRYN E · CIK 0001206977 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 59,171

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.85 to $7.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-036275 · doc4.xml · nonDerivative · entry 2

FALBERG KATHRYN E · CIK 0001206977 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 49,171

SEC source: 0001209191-19-036275 · doc4.xml · nonDerivative · entry 1

FALBERG KATHRYN E · CIK 0001206977 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 39,171

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.96 to $8.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-035453 · doc4.xml · nonDerivative · entry 2

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Rosen Family Trust

Disclosed balance after: 3,023,139

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.88 to $8.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-035745 · doc4.xml · derivative · entry 1

Hege Kristen · CIK 0001299171 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2029-06-05

F1 · derivative.exercise_date: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.

SEC source: 0001209191-19-035752 · doc4.xml · derivative · entry 1

KANEKO YASUNORI · CIK 0001277503 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2029-06-05

F1 · derivative.exercise_date: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.

SEC source: 0001209191-19-035749 · doc4.xml · derivative · entry 1

Jarrett Jennifer · CIK 0001671311 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2029-06-05

F1 · derivative.exercise_date: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.

SEC source: 0001209191-19-035743 · doc4.xml · derivative · entry 1

FALBERG KATHRYN E · CIK 0001206977 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2029-06-05

F1 · derivative.exercise_date: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.

SEC source: 0001209191-19-035740 · doc4.xml · derivative · entry 1

BEIER DAVID W · CIK 0001187054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2029-06-05

F1 · derivative.exercise_date: The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.

SEC source: 0001209191-19-035453 · doc4.xml · nonDerivative · entry 1

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Rosen Family Trust

Disclosed balance after: 3,020,759

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.73 to $8.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-034622 · doc4.xml · nonDerivative · entry 2

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By The RosenFamily Trust

Disclosed balance after: 3,001,401

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.42 to $8.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-034201 · doc4.xml · nonDerivative · entry 1

Jaen Juan C. · CIK 0001422996 · Director · President

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 2,764,240

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.05 to $8.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-034622 · doc4.xml · nonDerivative · entry 1

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Rosen Family Trust

Disclosed balance after: 2,975,631

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-19-026755 · doc4.xml · derivative · entry 1

Grossman William · CIK 0001730229 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2029-04-28

F1 · derivative.exercise_date: The option is exercisable in 48 equal monthly installments after April 29, 2019, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-19-021233 · doc4.xml · derivative · entry 1

Hemrajani Rekha · CIK 0001771213 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2029-03-24

F1 · derivative.exercise_date: The option is exercisable in 48 equal monthly installments after March 25, 2019, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-19-004497 · doc4.xml · derivative · entry 1

Chan Steven · CIK 0001654907 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2029-01-15

F1 · derivative.exercise_date: The option is exercisable in 48 equal monthly installments after January 16, 2019, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-19-004477 · doc4.xml · derivative · entry 1

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2029-01-15

F1 · derivative.exercise_date: The option is exercisable in 48 equal monthly installments after January 16, 2019, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-19-004478 · doc4.xml · derivative · entry 1

Jaen Juan C. · CIK 0001422996 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2029-01-15

F1 · derivative.exercise_date: The option is exercisable in 48 equal monthly installments after January 16, 2019, subject to the Reporting Person's continued service to the Company.

SEC source: 0000899243-19-001253 · doc4.xml · derivative · entry 1

Jarrett Jennifer · CIK 0001671311 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2029-01-13

F1 · derivative.exercise_date: The option is exercisable in 36 equal monthly installments after January 14, 2019, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-18-058692 · doc4.xml · nonDerivative · entry 1

Jaen Juan C. · CIK 0001422996 · Director · President

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 2,754,240

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.64 to $12.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0000899243-18-027179 · doc4.xml · derivative · entry 1

Hege Kristen · CIK 0001299171 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2028-10-18

F1 · derivative.exercise_date: The option is exercisable in 36 equal monthly installments after October 19, 2018, subject to the Reporting Person's continued service to the Company.

SEC source: 0001209191-18-048775 · doc4.xml · nonDerivative · entry 3

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 3,959,861

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.04 to $15.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-18-048775 · doc4.xml · nonDerivative · entry 2

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 3,949,211

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.89 to $14.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-18-048775 · doc4.xml · nonDerivative · entry 1

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 3,948,411

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.89 to $14.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-18-048417 · doc4.xml · nonDerivative · entry 3

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 3,941,254

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.20 to $13.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-18-048417 · doc4.xml · nonDerivative · entry 2

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 3,936,300

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.27 to $13.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-18-048417 · doc4.xml · nonDerivative · entry 1

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 3,934,167

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.36 to $13.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-18-047851 · doc4.xml · nonDerivative · entry 3

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 3,931,965

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.12 to $13.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-18-047851 · doc4.xml · nonDerivative · entry 2

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 3,929,175

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.07 to $13.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001209191-18-047851 · doc4.xml · nonDerivative · entry 1

ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 3,927,874

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.20 to $13.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.